Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Egeberg

Showing results (11-20 of 331) with videos related to

Pageof 34
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|June 26, 2024
Topical corticosteroids in the era of new topical therapies: Balancing efficacy and safety for long-term useAlexander Egeberg, Jacob P Thyssen
Annals of Plastic Surgery|July 9, 2014
The Impact of Breast Implant Location on the Risk of Capsular ContractionAlexander Egeberg, Jens Ahm Sørensen
Annals of the Rheumatic Diseases|August 3, 2017
Impact of age and sex on the incidence and prevalence of psoriatic arthritisAlexander Egeberg, Lars Erik Kristensen
Lancet (London, England)|February 6, 2023
The optimal biologic treatment target for hidradenitis suppurativa remains undiscoveredAlexander Egeberg, Jacob P Thyssen
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 3, 2019
Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in DenmarkJohan Burisch, Tine Jess, Alexander Egeberg
The Journal of Dermatological Treatment|November 15, 2023
A systematic review investigating at what proportion clinical images are shared in prospective randomized controlled trials involving patients with psoriasis and biological agentsSam Polesie, Farzad Alinaghi, Alexander Egeberg
Journal of the American Academy of Dermatology|June 7, 2019
Reply to: "Comment on 'Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis'"Alexander Egeberg, Lars Erik Bryld, Lone Skov
The Journal of Investigative Dermatology|April 24, 2017
Birth Outcomes in Children Fathered by Men Treated with Immunosuppressant Drugs before Conception-A Danish Population-Based Cohort StudyAlexander Egeberg, Gunnar H Gislason, Alexander Nast
The British Journal of Dermatology|October 7, 2023
Characteristics and prognosis of first-time hospitalized patients with generalized pustular psoriasis: insights from national databasesJeanette Halskou Haugaard, David Thein, Alexander Egeberg
Journal of the American Academy of Dermatology|March 28, 2019
Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasisAlexander Egeberg, Lars Erik Bryld, Lone Skov
Pageof 34

Showing results (11-20 of 331) with videos related to

Sort By:
Pageof 34
Journal of the European Academy of Dermatology and Venereology : JEADV|June 26, 2024
Topical corticosteroids in the era of new topical therapies: Balancing efficacy and safety for long-term useAlexander Egeberg, Jacob P Thyssen
Annals of Plastic Surgery|July 9, 2014
The Impact of Breast Implant Location on the Risk of Capsular ContractionAlexander Egeberg, Jens Ahm Sørensen
Annals of the Rheumatic Diseases|August 3, 2017
Impact of age and sex on the incidence and prevalence of psoriatic arthritisAlexander Egeberg, Lars Erik Kristensen
Lancet (London, England)|February 6, 2023
The optimal biologic treatment target for hidradenitis suppurativa remains undiscoveredAlexander Egeberg, Jacob P Thyssen
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 3, 2019
Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in DenmarkJohan Burisch, Tine Jess, Alexander Egeberg
The Journal of Dermatological Treatment|November 15, 2023
A systematic review investigating at what proportion clinical images are shared in prospective randomized controlled trials involving patients with psoriasis and biological agentsSam Polesie, Farzad Alinaghi, Alexander Egeberg
Journal of the American Academy of Dermatology|June 7, 2019
Reply to: "Comment on 'Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis'"Alexander Egeberg, Lars Erik Bryld, Lone Skov
The Journal of Investigative Dermatology|April 24, 2017
Birth Outcomes in Children Fathered by Men Treated with Immunosuppressant Drugs before Conception-A Danish Population-Based Cohort StudyAlexander Egeberg, Gunnar H Gislason, Alexander Nast
The British Journal of Dermatology|October 7, 2023
Characteristics and prognosis of first-time hospitalized patients with generalized pustular psoriasis: insights from national databasesJeanette Halskou Haugaard, David Thein, Alexander Egeberg
Journal of the American Academy of Dermatology|March 28, 2019
Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasisAlexander Egeberg, Lars Erik Bryld, Lone Skov
Pageof 34